1
|
Deng K, Yao J, Zeng S, Wen M, Huang J, Zhu T, Liu S, Zuo J. The effect of surgery plus intensity-modulated radiotherapy on treatment in laryngeal cancer: A clinical retrospective study. J Cancer Res Clin Oncol 2021; 148:517-525. [PMID: 33860848 DOI: 10.1007/s00432-021-03637-z] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2021] [Accepted: 04/08/2021] [Indexed: 10/21/2022]
Abstract
PURPOSE As a common head and neck tumor, laryngeal cancer has attracted heightened attention for its treatment and prognosis. Surgery and radiotherapy were mainly therapeutic approaches in laryngeal cancer, and intensity-modulated radiotherapy (IMRT) was a precision treatment way in radiotherapy. However, the therapeutic effect of surgery plus IMRT in laryngeal cancer was rarely reported. This study aims to determine the effect of IMRT on the treatment of patients with laryngeal cancer. METHODS A total of 125 patients with laryngeal cancer were collected and retrospectively analyzed based on their clinical data and follow-up results. These patients had a clear treatment plan for surgery and intensity-modulated radiotherapy. RESULTS Smoking, lymph node metastasis, TNM staging and therapeutic approaches could affect the survival of patients with laryngeal cancer. It was shown that the laryngeal function retention rate in the simple IMRT group was significantly higher than the simple surgery group and surgery plus IMRT group. The 5-year survival rate of surgery plus IMRT, simple surgery and simple IMRT were 82.86%, 53.85% and 43.33%, respectively. The locoregional recurrences rate of surgery plus IMRT, simple surgery and simple IMRT were 14.29%, 34.62% and 43.33%. CONCLUSION Surgery plus IMRT was a feasible and efficacious treatment technique for patients with laryngeal cancer, which effectively prolong the survival time of patients.
Collapse
Affiliation(s)
- Kun Deng
- The Laboratory of Translational Medicine, Hengyang Medical School, University of South China, 28 Changsheng Road, Hengyang, 421001, Hunan, People's Republic of China
| | - Jingwei Yao
- Nanhua Hospital of University of South China, Hengyang, 421002, Hunan, People's Republic of China
| | - Shuqing Zeng
- The First Affiliated Hospital of University of South China, Hengyang, 421000, Hunan, People's Republic of China
| | - Meiling Wen
- The First Affiliated Hospital of University of South China, Hengyang, 421000, Hunan, People's Republic of China
| | - Jialu Huang
- The Laboratory of Translational Medicine, Hengyang Medical School, University of South China, 28 Changsheng Road, Hengyang, 421001, Hunan, People's Republic of China
| | - Tao Zhu
- The First Affiliated Hospital of University of South China, Hengyang, 421000, Hunan, People's Republic of China
| | - Shanyan Liu
- Nanhua Hospital of University of South China, Hengyang, 421002, Hunan, People's Republic of China
| | - Jianhong Zuo
- The Laboratory of Translational Medicine, Hengyang Medical School, University of South China, 28 Changsheng Road, Hengyang, 421001, Hunan, People's Republic of China. .,Nanhua Hospital of University of South China, Hengyang, 421002, Hunan, People's Republic of China. .,The First Affiliated Hospital of University of South China, Hengyang, 421000, Hunan, People's Republic of China. .,Clinical Laboratory, The Third Affiliated Hospital of University of South China, Hengyang, 421900, Hunan, People's Republic of China.
| |
Collapse
|